Roche has signed a voluntary license agreement providing its popular influenza antiviral drug Xofluza (baloxavir marboxil) ...

May 18 (Reuters) - Roche and the Medicines Patent Pool have signed a licensing agreement to expand access to the Swiss ...

The Medicines Patent Pool (MPP) announced the rapid expansion of its network of generic manufacturers to 14 companies now working on more than 50 projects to develop MPP-licensed antiretrovirals (ARVs ...

The World Health Organization (WHO) and Medicines Patent Pool (MPP) have today announced a sublicensing agreement between MPP and a Nigerian health technology company – Codix Bio – to start ...

In an effort to bolster drug access in dozens of countries around the globe, three generics makers have obtained sublicenses to make low-cost versions of GSK’s long-acting HIV PrEP drug Apretude.

ViiV Healthcare, a global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, announced an update to their voluntary licensing agreement with the Medicines Patent ...